Product Presentation

Manufacturing Recombinant Protein Therapeutics under Cost Constraints

Format: PDF file | Document type: Product Presentation | Promoted Content

This content is provided by Rentschler Biotechnologie GmbH, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Manufacturing Recombinant Protein Therapeutics under Cost Constraints

Therapeutic proteins such as monoclonal antibodies and fusion proteins represent one of the fastest growing segments in the drug pipeline, which puts pressure on economical manufacturing. Therefore current manufacturing trends are focused on limiting effort, costs and risk. Typical approaches are for example applying disposables, reducing the number of steps in platform processes, using modular concepts and replacing costly affinity resins. Several case studies highlight successful process design, optimization strategies, and critical manufacturing parameters.

Supplier info centre